Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
AI In Life Science Analytics Market Growth From $3.13 Billion In 2026 To $6.16 Billion By 2030 At A CAGR Of 18.4%
The AI in life science analytics market has seen significant expansion in recent years. This market is anticipated to expand from $2.63 billion in 2025 to $3.13 billion in 2026, showing a compound annual growth rate (CAGR) of 19.0%. The historical growth of this market can be attributed to several factors, including the increasing volume of clinical and research data, the expansion of digital clinical trials, the growing application of analytics in pharmaceutical R&D, the adoption of data-driven decision making in life sciences, and improvements in data integration technologies.
The AI in life science analytics market is poised for substantial expansion over the next few years. It is projected to climb to $6.16 billion in 2030, growing at a compound annual growth rate (CAGR) of 18.4%. This anticipated growth throughout the forecast period stems from factors such as increasing demand for precision diagnostics, greater investments in AI-enabled drug development, broader adoption of cloud analytics, the expanding use of real-world evidence analytics, and a stronger focus on operational efficiency in life sciences. Prominent trends expected in the coming years include the growing deployment of AI-based clinical analytics tools, an uptick in predictive modeling for drug discovery, rising adoption of cloud-based life science analytics, the expansion of real-time data integration platforms, and a heightened emphasis on producing actionable insights.
Get A Free Sample Report With In-Depth Market Insights:
AI In Life Science Analytics Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing expenditure on healthcare is anticipated to drive the expansion of AI in the life science analytics market moving forward. Healthcare expenditure refers to the total financial outlay on healthcare goods and services within a specific timeframe, encompassing various costs related to medical treatment and public health initiatives. This rise in spending is attributed to the growing prevalence of chronic and lifestyle-related diseases, which demand long-term care, continuous medical management, and costly interventions. Consequently, healthcare expenditure stimulates the adoption of AI in life science analytics by financing advanced, data-driven tools that enhance research effectiveness, improve patient outcomes, and provide cost-efficient healthcare solutions. For instance, in May 2024, the Office of National Statistics, a UK-based government agency, reported that total healthcare expenditure nominally increased by 5.6% between 2022 and 2023, a significant rise compared to the 0.9% growth observed in 2022. Thus, increasing healthcare expenditure is fueling the growth of AI in the life science analytics market.
AI In Life Science Analytics Market Segment Breakdown: Which Categories Lead On Revenue?
The AI in life science analytics market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment: On-Premise, Cloud
3) By Application: Research And Development, Sales And Marketing Support, Supply Chain Analytics, Other Applications
4) By End-User: Medical Devices, Pharmaceutical, Biotechnology, Other End Users
Subsegments:
1) By Software: Data Analysis Software, Predictive Analytics Tools, Machine Learning Platforms, Visualization Software, Clinical Trial Management Software
2) By Hardware: Servers, Storage Solutions, Workstations, Networking Equipment
3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Management Services, Training Services
#AI In Life Science Analytics Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the AI in Life Science Analytics market are concentrating on developing innovative solutions, such as AI-powered multi-omics data analysis platforms, to enhance insights and precision in biomedical research. An AI-empowered multi-omics data analysis platform is a technology that leverages artificial intelligence to integrate and analyze diverse biological data types like genomics, proteomics, and metabolomics, aiming to uncover complex biological insights and support precision medicine. For instance, in October 2023, BioLizard, a biotechnology company based in Belgium, unveiled its new AI-empowered BioVerse platform to facilitate data-driven R&D for the global life sciences community. This platform is designed to offer customized, user-friendly software solutions for data-driven results, targeting scientists in biotech and pharma sectors, regardless of their IT background. The platform incorporates three applications: Bio|Reflect, which provides comprehensive overviews of publications for unbiased literature searches; Pro|Biome, which applies data analytics to microbiome analysis; and Bio|Mx, which utilizes AI to integrate and analyze multi-omics datasets. The primary goal of BioVerse is to streamline data-driven discovery and the preclinical, translational, and clinical R&D processes within the life sciences industry through the implementation of AI-driven solutions. This launch underscores BioLizard’s dedication to delivering AI-driven solutions that support data-driven discovery and the preclinical, translational, and clinical R&D processes in the life sciences industry.
AI In Life Science Analytics Market Leading Players And Competitive Positioning
Major companies operating in the AI in life science analytics market are Indegene Limited; International Business Machines Corporation; IQVIA Holdings Inc.; Databricks Inc.; SAS Institute Inc.; Sorcero; Atomwise Inc.; Microsoft Corporation; NVIDIA Corporation; Oracle Corporation; NuMedii Inc.; Enlitic Inc.; Apixio Inc.; AiCure LLC; Google LLC; Amazon Web Services Inc.; Accenture; BioSymetrics; Cloud Pharmaceuticals; Freenome; GNS Healthcare; Insilico Medicine; PathAI; Recursion Pharmaceuticals; Sophia Genetics; Veracyte Inc.; Lexalytics Inc.; Sisense Inc.; Cognitivescale; Ayasdi; Cyrcadia Health
View The Full AI In Life Science Analytics Market Report:
AI In Life Science Analytics Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the AI in life science analytics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the AI in life science analytics market report during the forecast period. The regions covered in the AI in life science analytics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
